Association Between SGLT2 Inhibitor Use and Post-Contrast Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Multicenter Cohort Study
Preprint
Abstract
Introduction: Patients with type 2 diabetes mellitus (T2DM) are at increased risk of coronary artery disease and frequently undergo coronary angiography or percutaneous coronary intervention. Although risk factors for post-contrast acute kidney injury (PC-AKI) are well defined, effective preventive strategies remain limited. Methods: This multicenter observational cohort study included 975 patients aged 18–75 years who underwent coronary angiography and/or percutaneous coronary intervention with iodinated contrast between June 2023 and June 2024. All patients received standardized intravenous hydration. Participants were grouped according to chronic sodium–glucose co-transporter-2 (SGLT2) inhibitor use (≥3 months). PC-AKI was defined as a ≥25% or ≥0.5 mg/dL increase in serum creatinine within 48–72 hours after contrast exposure. Results: The mean age was 59.2 ± 11.7 years, and 70.8% were male; 16.9% were using SGLT2 inhibitors. PC-AKI occurred in 7.3% of patients, and 0.7% required renal replacement therapy. In univariate analysis, advanced age, diabetes, hypertension, heart failure, diuretic use, and elevated urea, creatinine, potassium, and uric acid levels were associated with PC-AKI. Higher eGFR, albumin, sodium levels, and SGLT2 inhibitor use were inversely associated. In multivariate analysis, age ≥65.5 years (OR 4.53), diabetes (OR 2.49), and uric acid >6.75 mg/dL (OR 2.34) remained independent risk factors, while eGFR >81.5 mL/min/1.73 m 2 (OR 0.38), sodium >137.5 mmol/L (OR 0.36), and SGLT2 inhibitor use (OR 0.09) were independently protective. Conclusion: Beyond established cardioprotective and renoprotective effects, SGLT2 inhibitors may reduce the risk of PC-AKI in patients with T2DM, potentially through decreased renal oxygen consumption and attenuation of contrast-induced hypoxic injury.Keywords
This publication has 31 references indexed in Scilit:
- Mechanistic insights and clinical horizons of SGLT2 inhibitors in heart failure managementTrends in Cardiovascular Medicine, 2025
- Nocturia and SGLT2 inhibitors: A review of pathophysiology, clinical evidence, and therapeutic implicationsContinence, 2025
- A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol in more than 57,000 patients: part 1—intravenous administrationEuropean Radiology, 2022
- Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategiesEuropean Journal of Radiology, 2019
- Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factorsEuropean Radiology, 2018
- Acute kidney injury from SGLT2 inhibitors: potential mechanismsNature Reviews Nephrology, 2016
- Contrast-Induced Acute Kidney Injury: An UpdateCardiovascular Drugs and Therapy, 2016
- Contrast-induced nephropathy in patients with type 2 diabetes during coronary angiography: Risk-factors and prognostic valueDiabetes Research and Clinical Practice, 2009
- Angiography for renal artery stenosis: no additional impairment of renal function by angioplastyEuropean Radiology, 2001
- Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidneyKidney International, 1996